Enhanced by remote monitoring, telemedicine, and wearable devices, this market is booming across North America and Asia Pacific. Blood glucose monitoring dominates, while cardiac devices are rapidly ...

HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...

(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights ...

As per Future Market Insights’ latest industry analysis, the valuation for the global cardiac ambulatory monitoring market was around USD 13.9 Billion in 2022 and is projected to exhibit a CAGR close ...

Rhythm (Nasdaq: IRTC) today announced new results supporting its Zio long-term continuous monitoring (LTCM) ECG patch.

HeartBeam has announced a partnership with AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility.

HeartBeam (NASDAQ: BEAT) , a medical technology firm innovating in personalized cardiac care, has announced a strategic collaboration with AccurKardi ...

IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today unveiled new findings from its EVIDENCE-RM study¹. Leveraging extensive data from the French National ...

Backed by a voter-approved bond, St. Charles County Ambulance District is building its largest station and adding 70+ cardiac ...

Huawei has confirmed that it will unveil a new smartwatch with an intriguing new health sensor on May 15 – and if you don't ...

UCSF is launching a remote patient monitoring program aimed at identifying arrhythmias in expectant mothers and improving ...

Apple Watch users in the US have been unable to access the blood oxygen feature. Here’s when it might make a comeback.